Omega-3 And Omega-6 Fatty Acids

Verify with FDA CVM →

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Omega-3 And Omega-6 Fatty Acids

Administration Routes

OralUnknown

Species Affected

Dog 15

Most Affected Breeds

Shepherd Dog - Australian 2
Retriever - Labrador 2
Shih Tzu 2
Dalmatian 1
Bulldog 1
Spaniel (unspecified) 1
Terrier - West Highland White 1
Retriever - Golden 1
Terrier (unspecified) 1
Crossbred Canine/dog 1

Most Reported Reactions

Emesis 6
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy - NOS 2
Vomiting 1
Decreased appetite 1
Emesis (multiple) 1
Hives (see also 'Skin') 1
Diarrhoea 1
Pruritus 1
Behavioural disorder NOS 1
Reduced responses 1
Limping 1

Outcome Breakdown

Recovered/Normal
11 (73.3%)
Outcome Unknown
2 (13.3%)
Recovered with Sequela
2 (13.3%)

Data Summary

Metric Value
Total adverse event reports 15
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 1
Distinct breeds in reports 12
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Omega-3 And Omega-6 Fatty Acids Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 15 adverse event reports referencing Omega-3 And Omega-6 Fatty Acids, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Omega-3 And Omega-6 Fatty Acids. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Omega-3 And Omega-6 Fatty Acids reports are Dog (15 reports), with Dog accounting for the largest share. Within those species, Shepherd Dog - Australian (2), Retriever - Labrador (2), Shih Tzu (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Omega-3 And Omega-6 Fatty Acids are Emesis (6), Lethargy (see also Central nervous system depression in 'Neurological') (2), Lack of efficacy - NOS (2), Vomiting (1). Of the 15 reports with a coded outcome, Recovered/Normal is the leading category at 73.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Omega-3 And Omega-6 Fatty Acids.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial